LENZ Therapeutics Submits NDA for LNZ100 to NMPA in China
28 Jul 2025 //
GLOBENEWSWIRE
ADA 2025: Phase 2 CX11/VCT220 Trial Data in China Revealed
23 Jun 2025 //
GLOBENEWSWIRE
Corxel Gets FDA Approval for Phase 2 Trial of CX11 in Obesity
15 Apr 2025 //
GLOBENEWSWIRE